Tilray projects 9% annual revenue growth, targeting $1 billion in fiscal 2027 amid U.S. legalization hurdles and international opportunities.
Tilray Brands (NASDAQ: TLRY) expects full-year revenue to exceed $1 billion in fiscal 2027, a milestone following its 2026 fiscal year close at $915.5 million. The 11% year-over-year growth outpaced broader economic challenges, driven by international markets and beverage segment acquisitions.
The company’s prior-year revenue reached $821.3 million, reflecting steady expansion despite limited U.S. cannabis legalization. CEO Irwin Simon cited strength in Europe’s medical and cannabis sectors as key growth levers for the coming year.
Shares showed muted reaction as investors weigh execution risks against long-term potential in global markets.